Philips North America vs RARE THYROID THERAPEUTICS INTERNATIONAL AB: FDA Enforcement Comparison

Philips North America has been the subject of 357 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for RARE THYROID THERAPEUTICS INTERNATIONAL AB.

Philips North America: 0 warning letters, 357 recalls, 0 approval records, 0 Form 483s.

RARE THYROID THERAPEUTICS INTERNATIONAL AB: 0 warning letters, 0 recalls, 1 approval record, 0 Form 483s.

Side by side

Philips North America — Warning letters0

RARE THYROID THERAPEUTICS INTERNATIONAL AB — Warning letters0

Philips North America — Recalls357

RARE THYROID THERAPEUTICS INTERNATIONAL AB — Recalls0

Philips North America — Approval records0

RARE THYROID THERAPEUTICS INTERNATIONAL AB — Approval records1

Philips North America — Form 483s0

RARE THYROID THERAPEUTICS INTERNATIONAL AB — Form 483s0

Timeline

Philips North America

Most recent FDA action: September 23, 2026

Full history →

RARE THYROID THERAPEUTICS INTERNATIONAL AB

Most recent FDA action: September 28, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Philips North America vs RARE THYROID THERAPEUTICS INTERNATIONAL AB: FDA Enforcement Comparison." Argus HQ, accessed October 12, 2026. https://argushq.ai/compare/philips-north-america-vs-rare-thyroid-therapeutics-international-ab

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗